141: Small cell lung cancer: Is there a role for chemotherapy in patients with poor performance status?

Lung Cancer ◽

10.1016/s0169-5002(17)30191-5 ◽

2017 ◽

Vol 103 ◽

pp. S64

Author(s):

S. Massalha ◽

A. Mullard ◽

C. Fuller

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

Faculty Opinions recommendation of Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725268190.793503674 ◽

2015 ◽

Author(s):

Mellar Davis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Patients with non-small cell lung cancer and poor performance status: A significant population with limited data

Seminars in Oncology ◽

10.1053/j.seminoncol.2004.10.001 ◽

2004 ◽

Vol 31 ◽

pp. 1-2

Author(s):

Corey Langer ◽

Rogerio Lilenbaum

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Limited Data ◽

Small Cell Lung

Download Full-text

Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status

BMC Research Notes ◽

10.1186/1756-0500-1-102 ◽

2008 ◽

Vol 1 (1) ◽

pp. 102 ◽

Author(s):

Zhong Wei ◽

Wang Mengzhao ◽

Zhang Li ◽

Li Longyun ◽

Zhang Xiaotong

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Chinese Patients ◽

Poor Performance Status ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

Retrospective analysis of the management of extensive stage small cell lung cancer (SCLC) in patients with a poor performance status

Lung Cancer ◽

10.1016/s0169-5002(19)30246-6 ◽

2019 ◽

Vol 127 ◽

pp. S84

Author(s):

T. Moore ◽

L. Gossage ◽

C. Lopez Escola ◽

I. Hennig

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

Challenges in defining and identifying patients with non-small cell lung cancer and poor performance status

Seminars in Oncology ◽

10.1053/j.seminoncol.2004.10.003 ◽

2004 ◽

Vol 31 ◽

pp. 3-7 ◽

Author(s):

Karen Kelly

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

P-579 Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status

Lung Cancer ◽

10.1016/s0169-5002(03)92546-3 ◽

2003 ◽

Vol 41 ◽

pp. S237 ◽

Author(s):

Joseph Treat ◽

Chao Hui Huang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era

Current Oncology Reports ◽

10.1007/s11912-019-0852-9 ◽

2019 ◽

Vol 21 (12) ◽

Author(s):

Alex Friedlaender ◽

Giuseppe Luigi Banna ◽

Lucio Buffoni ◽

Alfredo Addeo

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung ◽

Status Assessment

Download Full-text

Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status

Annals of Oncology ◽

10.1093/annonc/mdy425.029 ◽

2018 ◽

Vol 29 ◽

pp. ix160

Author(s):

K. Hashimoto ◽

Y. Okuma ◽

T. Hakozaki ◽

K. Watanabe ◽

Y. Hosomi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Egfr Mutations ◽

Poor Performance Status ◽

Small Cell Lung ◽

Download Full-text

The role of chemotherapy in patients with small cell lung cancer and poor performance status

Acta Oncologica ◽

10.1080/0284186x.2020.1819562 ◽

2020 ◽

Vol 59 (12) ◽

pp. 1520-1527

Author(s):

Vanita Noronha ◽

Rahul Ravind ◽

Vijay M. Patil ◽

Smruti Mokal ◽

Amit Joshi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7057 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7057-7057 ◽

Author(s):

R. Lilenbaum ◽

M. Rubin ◽

J. Samuel ◽

L. Boros ◽

T. Chidiac ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text